Profile
Robert D.
Tessarolo formerly worked at Cipher Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2017 to 2019, NeonMind Biosciences, Inc., as President & Chief Executive Officer from 2021 to 2022, Mind Medicine (MindMed), Inc., as President, Chief Executive Officer & Director from 2019 to 2020, Bradmer Pharmaceuticals, Inc., as Director from 2010 to 2012, Lancaster Resources, Inc., as Director from 2022 to 2023, Celgene Corp., as Vice President & General Manager from 2015 to 2017, Biovail Pharmaceuticals LLC, as Vice President & General Manager from 2009 to 2010, and Allergan Pharma Co., as President & General Manager from 2011 to 2015.
Mr. Tessarolo received his undergraduate degree from Carleton University.
Former positions of Robert Tessarolo
Companies | Position | End |
---|---|---|
LANCASTER RESOURCES INC. | Director/Board Member | 2023-06-22 |
MIND MEDICINE (MINDMED) INC. | Chief Executive Officer | 2019-12-31 |
CIPHER PHARMACEUTICALS INC. | Chief Executive Officer | 2019-07-28 |
CELGENE | Corporate Officer/Principal | 2017-03-30 |
Allergan Pharma Co.
Allergan Pharma Co. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Allergan Pharma Co. is a Canadian company that manufactures and wholesales pharmaceutical products. The private company is based in Oakville, Canada. | President | 2015-04-30 |
Training of Robert Tessarolo
Carleton University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
CIPHER PHARMACEUTICALS INC. | Health Technology |
MIND MEDICINE (MINDMED) INC. | Health Technology |
LANCASTER RESOURCES INC. | Process Industries |
Private companies | 5 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Bradmer Pharmaceuticals, Inc.
Bradmer Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bradmer Pharmaceuticals, Inc. engaged in the development and commercialization of cancer therapies. The company was founded on June 16, 2005 and wass headquartered in Toronto, Canada. | Commercial Services |
Biovail Pharmaceuticals LLC
Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Biovail Pharmaceuticals, Inc. researches and develops pharmaceutical medicines. The company products include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. The company is headquartered in Bridgewater, NJ. | Health Technology |
Allergan Pharma Co.
Allergan Pharma Co. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Allergan Pharma Co. is a Canadian company that manufactures and wholesales pharmaceutical products. The private company is based in Oakville, Canada. | Health Technology |
NeonMind Biosciences, Inc.
NeonMind Biosciences, Inc. Pharmaceuticals: OtherHealth Technology NeonMind Biosciences, Inc. focuses in drug development to evaluate the safety and efficacy of psychedelic substances for therapeutic uses as approved medicines. It operates through the Pharmaceutical, and Consumer divisions. The Pharmaceutical division deals with drug development of psychedelic compounds and a consumer products division with a focus on mushroom infused products including functional foods, natural health products, and dietary supplements. The Consumer divisions engages in the sale of four branded coffee products in Canada through NeonMind's direct to consumer e-commerce platform. The company was founded by Jeff B. Smith and Penny White in 2019 and is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Robert Tessarolo